AUPHNasdaq Canada
Market cap
$2.060 B
$15.85 -1.74%
Close of 7 Aug 2026
Revenue
$283.1M
#2158 by revenue
Earnings
$287.2M
#859 by earnings
Shares outstanding
133,051,168
Latest filing cover page
P/E ratio
7.2
Cap ÷ net income
Where these numbers come from
Share counts and financials for Aurinia Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.